Q1: 2026-05-05 Earnings Summary
EPS of -$2.28 misses by $0.03
|
Revenue of
$138.05M
(-33.28% Y/Y)
misses by $44.09M
BioNTech SE (BNTX) Q1 2026 Earnings Call May 5, 2026 8:00 AM EDT
Company Participants
Douglas Maffei - Vice President of Strategy & Investor Relations
Ugur Sahin - Co-Founder, CEO & Chair of the Management Board
Özlem Türeci - Co-Founder, Chief Medical Officer & Member of Management Board
Ramón Zapata-Gomez - CFO & Member of Management Board
Annemarie Hanekamp - Chief Commercial Officer & Member of Management Board
Conference Call Participants
Daina Graybosch - Leerink Partners LLC, Research Division
Jessica Fye - JPMorgan Chase & Co, Research Division
Tazeen Ahmad - BofA Securities, Research Division
Manoj Eradath - Jefferies LLC, Research Division
Xiaochuan Dai - UBS Investment Bank, Research Division
Asad Haider - Goldman Sachs Group, Inc., Research Division
Terence Flynn - Morgan Stanley, Research Division
Evan Seigerman - BMO Capital Markets Equity Research
Cory Kasimov - Evercore ISI Institutional Equities, Research Division
Mohit Bansal - Wells Fargo Securities, LLC, Research Division
Harry Gillis - Joh. Berenberg, Gossler & Co. KG, Research Division
Presentation
Douglas Maffei
Vice President of Strategy & Investor Relations
Thank you, operator. Good morning and good afternoon. Thank you for joining BioNTech's First Quarter 2026 Earnings Call. As a reminder, the slides we will use during this call and the corresponding press release can be found in the Investors section of our website.
On the next slide, you will see our forward-looking statements disclaimer. Additional information about these statements and other risks are described in our filings with the U.S. Securities and Exchange Commission, or SEC.
Forward-looking statements on this call are subject to significant risks and uncertainties and speak only as of the date of this conference call. We undertake no obligation to update or revise any of these statements.
On Slide 3, you can find the agenda for today's call. I'm joined by the following members of BioNTech's management team: Ugur Sahin, Chief Executive Officer and Co-Founder; Ozlem Tureci, Chief Medical Officer and
此内容由惯性聚合(RSS阅读器)自动聚合整理，仅供阅读参考。 原文来自 — 版权归原作者所有。